Nevada
|
87-0431533
|
(State or other jurisdiction
|
(IRS Employer Identification No.)
|
of incorporation or organization)
|
Page | |||
PART I-FINANCIAL INFORMATION | |||
Item 1. Financial Statements
|
|||
Balance Sheets
|
|||
(Unaudited) as of March 31, 2012 and December 31, 2011
|
3
|
||
Statements of Operations
|
|||
(Unaudited) for the Three Months Ended March 31, 2012 and 2011 and
|
|||
from inception of exploration stage to March 31, 2012
|
4
|
||
Statements of Cash Flows (Unaudited)
|
|||
for the Three Months Ended March 31, 2012 and 2011 and
|
|||
from inception of exploration stage to March 31, 2012
|
5
|
||
Notes to Financial Statements (Unaudited)
|
6
|
||
Item 2. Management's Discussion and Analysis of Financial Condition and
|
|||
Results of Operations
|
8
|
||
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
|
8
|
||
Item 4. Controls and Procedures
|
8
|
||
PART II - OTHER INFORMATION
|
|||
Item 1. Legal Proceedings | 11 | ||
Item 1A. Risk Factors
|
11 | ||
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
11 | ||
Item 3. Defaults Upon Senior Securities
|
11 | ||
Item 4. Mine Safety Disclosure
|
11 | ||
Item 5. Other Information
|
11 | ||
Item 6. Exhibits
|
11 | ||
Signatures
|
12 |
March 31, 2012
|
December 31, 2011
|
|||||||
ASSETS
|
(Unaudited)
|
(Audited)
|
||||||
Current Assets
|
||||||||
Cash
|
$ | 374,017 | $ | 214,517 | ||||
Total Current Assets
|
374,017 | 214,517 | ||||||
Fixed assets (net of depreciation)
|
56,307 | 57,936 | ||||||
Total Other Assets
|
56,307 | 57,936 | ||||||
Total Assets
|
$ | 430,324 | $ | 272,453 | ||||
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
Current Liabilities
|
||||||||
Trade accounts payable
|
$ | 55,751 | $ | 36,214 | ||||
Accrued interest
|
45,833 | 18,333 | ||||||
Notes payable
|
1,100,000 | 1,100,000 | ||||||
Proceeds for common stock to be issued
|
1,360,000 | 1,360,000 | ||||||
Warrants derivative liability
|
3,247,109 | 11,128,157 | ||||||
Total Current Liabilities
|
5,808,693 | 13,642,704 | ||||||
Stockholders' Deficit
|
||||||||
Common stock - $0.001 par value; 100,000,000 shares authorized; 33,138,726 and 32,348,726 shares outstanding, respectively
|
33,138 | 32,348 | ||||||
Additional paid-in-capital
|
47,383,386 | 46,494,730 | ||||||
Accumulated deficit
|
(23,315,973 | ) | (23,315,973 | ) | ||||
Exploration stage deficit
|
(29,478,920 | ) | (36,581,356 | ) | ||||
Total Stockholders' Deficit
|
(5,378,369 | ) | (13,370,251 | ) | ||||
Total Liabilities and Stockholders' Deficit
|
$ | 430,324 | $ | 272,453 |
For the Three Months Ended
|
From Inception of
|
|||||||||||
March 31,
|
Exploration Stage
|
|||||||||||
January 1, 2010
|
||||||||||||
through
|
||||||||||||
2012
|
2011
|
March 31, 2012
|
||||||||||
Sales
|
$ | - | $ | - | $ | - | ||||||
Expenses
|
||||||||||||
General and administrative
|
960,206 | 1,308,395 | 21,108,645 | |||||||||
Total Expenses
|
960,206 | 1,308,395 | 21,108,645 | |||||||||
Operating Loss
|
(960,206 | ) | (1,308,395 | ) | (21,108,645 | ) | ||||||
Other income (expense)
|
||||||||||||
Gain (Loss) on derivative
|
8,090,003 | (7,983,331 | ) | 4,760,571 | ||||||||
Derivative day-one loss
|
- | - | (11,970,479 | ) | ||||||||
Interest expense
|
(27,500 | ) | - | (1,163,833 | ) | |||||||
Interest income
|
139 | 856 | 3,466 | |||||||||
Net Income (Loss)
|
$ | 7,102,436 | $ | (9,290,870 | ) | $ | (29,478,920 | ) | ||||
Basic and Diluted Net Gain (Loss) Per Common Share
|
$ | 0.22 | $ | (0.31 | ) | |||||||
Basic and Diluted Weighted Average Common Shares Outstanding
|
32,689,605 | 29,548,448 |
From Inception of
|
||||||||||||
For the Three Months Ended
|
Exploration Stage
|
|||||||||||
March 31,
|
January 1, 2010
|
|||||||||||
Through
|
||||||||||||
2012
|
2011
|
March 31, 2012
|
||||||||||
Cash Flows From Operating Activities
|
||||||||||||
Net income (loss)
|
$ | 7,102,435 | $ | (9,290,870 | ) | $ | (29,478,920 | ) | ||||
Adjustments to reconcile net income to net cash used in operating activities:
|
||||||||||||
Common stock and options issued for services
|
718,402 | 89,647 | 18,871,175 | |||||||||
(Gain) Loss on warrant derivative
|
(8,090,003 | ) | 8,897,086 | (4,815,570 | ) | |||||||
Derivative day-one loss
|
- | - | 11,970,479 | |||||||||
Depreciation expense
|
1,629 | - | 2,583 | |||||||||
Changes in operating assets and liabilities:
|
||||||||||||
Increase (decrease) in trade accounts payable
|
19,537 | (44,776 | ) | 47,065 | ||||||||
Increase (decrease) in accrued liabilities
|
27,500 | - | 31,095 | |||||||||
Net Cash Used in Operating Activities
|
(220,500 | ) | (348,913 | ) | (3,372,093 | ) | ||||||
Cash Flows From Investing Activities
|
||||||||||||
Investment in fixed assets
|
- | - | (58,890 | ) | ||||||||
Investment in mining rights project
|
- | (220,458 | ) | - | ||||||||
Net Cash Provided (Used) by Investing Activities
|
- | (220,458 | ) | (58,890 | ) | |||||||
Cash Flows From Financing Activities
|
||||||||||||
Proceeds from notes payable
|
- | - | 1,600,000 | |||||||||
Repayments of notes payable
|
- | - | (500,000 | ) | ||||||||
Proceeds from exercise of warrants for
|
||||||||||||
common stock to be issued
|
- | - | 1,360,000 | |||||||||
Purchase treasury stock
|
- | - | (60,000 | ) | ||||||||
Proceeds from issuance of common stock with warrants
|
380,000 | - | 1,405,000 | |||||||||
Net Cash Provided (Used) by Financing Activities
|
380,000 | - | 3,805,000 | |||||||||
Net Increase (decrease) in Cash
|
159,500 | (569,371 | ) | 374,017 | ||||||||
Cash at Beginning of Period
|
214,517 | 1,146,936 | - | |||||||||
Cash at End of Period
|
$ | 374,017 | $ | 577,565 | $ | 374,017 | ||||||
Non-Cash Investing and Financing Activities:
|
||||||||||||
Investing in mining rights in accounts payable
|
- | 69,494 | - |
Range of
exercise price
|
Number
Outstanding
|
Weighted
Average
Remaining
Contractual Life
(in years)
|
Weighted
Average
Exercise Price
|
Aggregate
Intrinsic
Value
|
|||||||||||
$ | 0.14 to $1.00 | 8,330,000 |
4.12 years
|
$ | 0.49 | $ | 4,081,700 |
(a) | Exhibits. | ||
31.1
|
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
31.2
|
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
32.1
|
Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)
|
||
99.1
|
Press release brazil
|
||
99.2
|
Press release Amery
|
||
Set forth below are the additional exhibits for the filing based on the new XBRL rules.
|
|||
101.INS |
XBRL Instance
|
||
101.XSD |
XBRL Schema
|
||
101.CAL |
XBRL Calculation
|
||
101.DEF | XBRL Definition | ||
101.LAB | XBRL Label | ||
101.PRE |
XBRL Presentation
|
ENSURGE, INC.
|
||
May 14, 2012
|
By:
|
/s/ Jordan M. Estra
|
Jordan M. Estra, Chief Executive Officer
(Principal Executive Officer)
|
||
May 14, 2012
|
By:
|
/s/ Jeff A. Hanks
|
Jeff A. Hanks, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
|
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
By: /s/ Jordan M. Estra
|
Chief Executive Officer
|
May 14, 2012
|
||
D Jordan M. Estra
|
(Principal Executive Officer)
|
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
By: /s/ Jeff A. Hanks
|
Chief Financial Officer
|
May 14, 2012
|
||
D Jeff A. Hanks
|
( (Principal Financial and Accounting Officer)
|
CERTIFICATION PURSUANT TO
|
18 U.S.C. SECTION 1350
|
AS ADOPTED PURSUANT TO
|
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
|
By: /s/ Jordan M. Estra
|
Chief Executive Officer
|
May 14, 2012
|
||
Jordan M. Estra
|
(Principal Executive Officer)
|
By: /s/ Jeff A. Hanks
|
Chief Financial Officer
|
May 14, 2012
|
||
Jeff A. Hanks
|
(Principal Financial and Accounting Officer )
|
YK(;G*G*ZE4WN&%YV"U7=BZF\RIQ2S WF*>>(^VX>;HCO94F/D>+IGLZ1VRU9()% -2R4IGVC<$`:5HRYQSAYH/
M4!&HM;O5?PU7SA/[>$UO9W<1BN<0+<_@#>^KP6^O_4Z0BJ*#DRUQNBL(HQAB
M0)[016;2]-(;@YJMU7`H?;SSI.HHOOX4X=7=^IB$+H(.AF '`ZB=MN8B+HJ
ML]0-K/(91;!/'6W/#4=.-9-6&APU246^D(G<4_13>=@5`4X\8'2'X`\AL4`"
M_P_H53DD>9B6]=)&N:)8.KBGA%/X`/(I]S;4;0.3HBZ*\*HU1[V$,JDYEP4=
M3(8KM>AFSG&Q#5MR!0ABCXQZG>OEV_TD?#<7[F$`)*[^D$-[3OH1"/Y:JF/U%(?&06C7E
M'<8HIP>[YQ&ZABLR9W<.5@M2EG?4CU)6%DXK3#DE#&)Z@K@F>T9V%F42[(8&
MHA:)T&`\O416*^ND%%I=$WI]Q%;/G("()'?_BGH8C*#FBJ.S8I_>>`\)CF\O
MP2%&;GEW2(\2>6[/NWE]9.#9P7+YQG3%9&6^:RMG261[11ITLKNXIW*9E/_?
MD+/$*,;T?@WG
SUBSEQUENT EVENTS
|
3 Months Ended |
---|---|
Mar. 31, 2012
|
|
Subsequent Events | |
Subsequent Events [Text Block] | NOTE 4 SUBSEQUENT EVENTS The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued, and has determined there are no other events to disclose. |
ISSUANCE OF STOCK
|
3 Months Ended |
---|---|
Mar. 31, 2012
|
|
Equity | |
Stockholders' Equity Note Disclosure [Text Block] | NOTE 3 ISSUANCE OF STOCK In February 2012, the Company entered into a contract with Andrew Barwicki, Inc. for investor relation consulting services. The Company pays Andrew Barwicki a monthly fee of $3,600 along with a one-time payment of 30,000 shares of the Companys common stock valued at $0.50 per share. Effective March 2, 2012, the Company accepted private placement funds from accredited investors. A total of $380,000 was received in exchange for units consisting of seven hundred sixty thousand (760,000) shares of the Companys common stock, plus three hundred eighty thousand (380,000) warrants with an exercise price of $1.00. The warrants are exercisable over a term of five years. All investors were accredited investors. The Company believes the sale of the units are exempt from registration, pursuant to Section 4(2) of the Securities Act of 1933 (as amended), as a private transaction not involving a public offering as well as Regulation D, Rule 506. |
BALANCE SHEETS (USD $)
|
Mar. 31, 2012
|
Dec. 31, 2011
|
---|---|---|
Cash | $ 374,017 | $ 214,517 |
Total Current Assets | 374,017 | 214,517 |
Fixed assets (net of depreciation) | 56,307 | 57,936 |
Total Other Assets | 56,307 | 57,936 |
Total Assets | 430,324 | 272,453 |
Trade accounts payable | 55,751 | 36,214 |
Accrued interest | 45,833 | 18,333 |
Notes payable | 1,100,000 | 1,100,000 |
Proceeds for common stock to be issued | 1,360,000 | 1,360,000 |
Warrants derivative liability | 3,247,109 | 11,128,157 |
Total Current Liabilities | 5,808,693 | 13,642,704 |
Common stock - $0.001 par value; 100,000,000 shares authorized; 33,138,726 and 32,348,726 shares outstanding, respectively | 33,138 | 32,348 |
Additional paid-in-capital | 47,383,386 | 46,494,730 |
Accumulated deficit | (23,315,973) | (23,315,973) |
Exploration stage deficit | (29,478,920) | (36,581,356) |
Total Stockholders' Deficit | (5,378,369) | (13,370,251) |
Total Liabilities and Stockholders' Deficit | $ 430,324 | $ 272,453 |
ORGANIZATION AND BASIS OF PRESENTATION
|
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements | |||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | NOTE 1–ORGANIZATION AND BASIS OF PRESENTATION Organization and Liquidation – On October 16, 2000, iShopper.com, Inc. changed its name to Ensurge, Inc., which is referred to herein as the Company. On January 1, 2002, the Company began liquidation of its assets. During 2009, the Company started a new phase of operations. Accordingly, financial statements are presented on a GAAP basis of accounting rather than on a liquidation basis. Basis of Presentation – The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q. Accordingly, these financial statements do not include all of the information and disclosures required by generally accepted accounting principles for complete financial statements. These unaudited condensed financial statements should be read in conjunction with the Company’s annual financial statements and the notes thereto for the year ended December 31, 2011, included in the Company’s annual report on Form 10-K, especially the information included in Note 1 to those financial statements, “Summary of Significant Accounting Policies.” In the opinion of the Company’s management, the accompanying unaudited condensed financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to fairly present the Company’s financial position as of March 31, 2012, and its results of operations and cash flows for the three months ended March 31, 2012 and 2011. The results of operations for the three months ended March 31, 2012, may not be indicative of the results that may be expected for the year ending December 31, 2012. Business Condition – The Company has suffered losses from operations, and the Company had a working capital deficit in the amount $5,434,676 at March 31, 2012. During 2010, the Company sold an aggregate of 3,100,000 shares of common stock to investors for an aggregate purchase price of $894,900 in a private placement. The Company received $1,360,000 for exercise of warrants to purchase 5,600,000 shares of the Company’s common stock. In August 2011 the Company entered into a 90 day note payable in the amount of $500,000. During the month of October 2011 the Company entered into two twelve month convertible Notes Payable for $605,000 each, for a total funding of $1,210,000, with an initial issue discount of 10% and total proceeds of $1,100,000, which are collateralized by all the assets of the Company. Proceeds were used to repay the $500,000 August 2011 note. These notes may be converted at a fixed price of $1.50 per share of the Company’s common stock, which may be converted at the option of the lender. These notes also include 950,000 warrants each for a total of 1,900,000 warrants at an exercise price of $1.00 per share and have a cashless exercise provision. The warrants have a 5 year term. In case of default, the Note may be converted into common stock at $1.50 per share or 80% of the current market bid price, whichever is lower. Effective March 2, 2012, the Company accepted $380,000 in private placement funds from accredited investors in exchange for units consisting of seven hundred sixty thousand (760,000) shares of the Company’s common stock, plus three hundred eighty thousand (380,000) warrants with an exercise price of $1.00. The proceeds of the financing are being used by the Company to fund the exploration for gold mines or to acquire relating mining assets, either directly or through one or more partnerships or joint ventures, in Brazil or elsewhere in South America. Basic and Diluted Loss Per Share – Basic loss per common share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per share is calculated to give effect to potentially issuable common shares, which include stock options and stock warrants except during loss periods when those potentially issuable common shares would decrease loss per share. As of March 31, 2012, the Company had a total of 8,330,000 warrants outstanding which all have a 5 year term. As of March 31, 2012, the Company had a total of 7,500,000 options of which 5,925,000 have vested and none have been exercised. The options are all 10 year options with an exercise price ranging from $0.14 to $0.50. Warrants: The Company has granted warrants to purchase shares of Common Stock. Warrants outstanding and exercisable at March 31, 2012 are as follows:
Recently-Enacted Accounting Standards Accounting Standards Update (“ASU”) No. 2009-05 (ASC Topic 820), which amends Fair Value Measurements and Disclosures – Overall, ASU No. 2009-13 (ASC Topic 605), Multiple-Deliverable Revenue Arrangements, ASU No. 2009-14 (ASC Topic 985), Certain Revenue Arrangements that include Software Elements, and various other ASU’s No. 2009-2 through ASU No. 2011-12, which contain technical corrections to existing guidance or affect guidance to specialized industries or entities were recently issued. These updates have no current applicability to the Company or their effect on the financial statements would not have been significant. |
"+ text.join( "
\n" ) +"
" + text[p] + "
\n"; } } }else{ formatted = '' + raw + '
'; } html = ''+ "\n"+''+ "\n"+''+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+' | '+ "\n"+'
'+ "\n"+' | '+ "\n"+' '+ "\n"+'
'+ "\n"+' | '+ "\n"+' '+ "\n"+'
COMMITMENTS AND CONTINGENCIES
|
3 Months Ended |
---|---|
Mar. 31, 2012
|
|
Commitment and Contingencies | |
Commitments and Contingencies Disclosure [Text Block] | NOTE 2 COMMITMENTS AND CONTINGENCIES None |
BALANCE SHEETS (PARENTHETICAL) (USD $)
|
Mar. 31, 2012
|
Dec. 31, 2011
|
---|---|---|
Common Stock par value | $ 0.001 | $ 0.001 |
Common stock shares authorized | 100,000,000 | 100,000,000 |
Common stock shares outstanding | 33,138,726 | 32,348,726 |
Document and Entity Information
|
3 Months Ended | |
---|---|---|
Mar. 31, 2012
|
May 14, 2012
|
|
Document and Entity Information | ||
Entity Registrant Name | ENSURGE INC | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2012 | |
Amendment Flag | false | |
Entity Central Index Key | 0000789879 | |
Current Fiscal Year End Date | --12-31 | |
Entity Common Stock, Shares Outstanding | 33,138,726 | |
Entity Filer Category | Smaller Reporting Company | |
Entity Current Reporting Status | Yes | |
Entity Voluntary Filers | No | |
Entity Well-known Seasoned Issuer | No | |
Document Fiscal Year Focus | 2012 | |
Document Fiscal Period Focus | Q1 |
STATEMENTS OF OPERATIONS (USD $)
|
3 Months Ended | 27 Months Ended | |
---|---|---|---|
Mar. 31, 2012
|
Mar. 31, 2011
|
Mar. 31, 2012
|
|
Sales | |||
General and administrative | 960,206 | 1,308,395 | 21,108,645 |
Total Expenses | 960,206 | 1,308,395 | 21,108,645 |
Operating Loss | (960,206) | (1,308,395) | (21,108,645) |
Gain (Loss) on derivative | 8,090,003 | (7,983,331) | 4,760,571 |
Derivative day-one loss | (11,970,479) | ||
Interest Expense | (27,500) | (1,163,833) | |
Interest income | 139 | 856 | 3,466 |
Net Income (Loss) | $ 7,102,435 | $ (9,290,870) | $ (29,478,920) |
Basic and Diluted Net Gain (Loss) Per Common Share | $ 0.22 | $ (0.31) | |
Basic and Diluted Weighted Average Common Shares Outstanding | 32,689,605 | 29,548,448 |